Chapter 3
Julian moved back to Clara’s side, sliding his jacket off and folding it neatly to place beneath her head as a makeshift pillow. The clinical coldness of the marble was steadily dropping her core body temperature, and the shock from her fall was beginning to manifest in mild tremors across her hands.
"We need to move her away from the foyer," Julian said, looking up at Walter. "The draft from the main entrance is too strong, and if someone breaches the perimeter glass, this room offers zero cover."
Walter nodded, taking Clara by her uninjured left arm while Julian supported her legs. Together, they lifted her with practiced coordination, carrying her past the grand staircase toward the dimly lit library that extended into the eastern wing of the mansion. The room smelled of old leather, aged paper, and the faint, comforting trace of cedarwood fire from the unlit hearth.
They placed her gently onto a velvet chesterfield sofa positioned near the center of the room. Clara closed her eyes for a brief moment, letting out a slow, ragged breath as the throbbing in her right wrist subsided into a dull, rhythmic ache.
"The medical bag," Clara murmured without opening her eyes. "I managed to salvage three vials of the baseline antidote before I left the supply closet. They’re in the front pocket of my scrub top."
Walter reached down, carefully unzipping the reinforced canvas pocket and pulling out three small, amber-glass vials intact despite the violent fall. He held them up to the soft desk lamp illumination, checking the serial numbers etched into the glass against a mental ledger of foundation inventory.
"These are batch 4-B," Walter said, his eyebrows knitting together. "The same batch allocated for the executive committee's private wellness program. Why would experimental neuro-regenerative antidotes be stored in the executive wing?"
May you like
"Because the executive committee isn't funding a cure," Clara said, opening her eyes to look directly at Julian. "They’re funding an enhancement. The memory-retention trials we’ve been running for the past two years? They weren't designed to heal degenerative brain diseases. They were designed to create permanent, docile compliance in high-level financial targets."
Julian stood by the mahogany bookshelf, his hands resting flat against the polished wood. The revelation did not trigger the explosive anger Walter expected. Instead, Julian’s posture grew perfectly still, his mind calculating the intricate web of shell companies and proxy boards that controlled the Vance Foundation’s capital investments.
